• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[造血系统恶性肿瘤合并弥散性血管内凝血患者的血浆纤维蛋白监测水平]

[Plasma fibrin monitor level in DIC patients with a hematopoietic malignancy].

作者信息

Hiyoyama K, Wada H, Shimura M, Deguchi H, Nagaya S, Wakita Y, Deguchi K, Shiku H

机构信息

2nd Department of Internal Medicine, Mie University School of Medicine, Tsu, Japan.

出版信息

Rinsho Byori. 1996 Jan;44(1):57-60.

PMID:8691641
Abstract

The Plasma level of soluble fibrin monomer (sFM) was measured in 218 patients with a hematopoietic malignancy. Of them, 198 were diagnosed with disseminates intravascular coagulation (DIC), 20 with Pre-DIC, and 20 with Non-DIC. Pre-DIC was retrospectively defined as the condition at least 1 week before the onset of DIC. The plasma levels of sFM, thrombin-anti-thrombin III complex (TAT), plasmin alpha 2-antiplasmin inhibitor complex (PIC), and FDP-D-dimer were significantly higher in patients with DIC than in those with Non-DIC. These levels were significantly higher in patients with Pre-DIC than in those with Non-DIC. Among these hemostatic parameters, the plasma sFM showed the highest sensitivity and specificity for DIC or Pre-DIC. These findings suggests that sFM is the most valuable marker hemostatic for the diagnosis of DIC and Pre-DIC.

摘要

对218例血液系统恶性肿瘤患者测定了可溶性纤维蛋白单体(sFM)的血浆水平。其中,198例被诊断为弥散性血管内凝血(DIC),20例为DIC前期(Pre-DIC),20例为非DIC。Pre-DIC被回顾性定义为DIC发病前至少1周的状态。DIC患者的sFM、凝血酶 - 抗凝血酶III复合物(TAT)、纤溶酶α2 - 抗纤溶酶抑制剂复合物(PIC)和FDP - D - 二聚体的血浆水平显著高于非DIC患者。Pre-DIC患者的这些水平显著高于非DIC患者。在这些止血参数中,血浆sFM对DIC或Pre-DIC表现出最高的敏感性和特异性。这些发现表明,sFM是诊断DIC和Pre-DIC最有价值的止血标志物。

相似文献

1
[Plasma fibrin monitor level in DIC patients with a hematopoietic malignancy].[造血系统恶性肿瘤合并弥散性血管内凝血患者的血浆纤维蛋白监测水平]
Rinsho Byori. 1996 Jan;44(1):57-60.
2
Diagnosis of pre-disseminated intravascular coagulation stage with hemostatic molecular markers. The Mie DIC Study Group.采用止血分子标志物诊断血管内凝血前期。三重县弥散性血管内凝血研究组。
Pol J Pharmacol. 1996 Mar-Apr;48(2):225-8.
3
Increased plasma-soluble fibrin monomer levels in patients with disseminated intravascular coagulation.弥散性血管内凝血患者血浆可溶性纤维蛋白单体水平升高。
Am J Hematol. 1996 Apr;51(4):255-60. doi: 10.1002/(SICI)1096-8652(199604)51:4<255::AID-AJH1>3.0.CO;2-V.
4
Hemostatic molecular markers before onset of disseminated intravascular coagulation in leukemic patients.白血病患者弥散性血管内凝血发作前的止血分子标志物。
Semin Thromb Hemost. 1998;24(3):293-7. doi: 10.1055/s-2007-995857.
5
[Clinical application of laboratory diagnosis: leukemia and DIC].[实验室诊断的临床应用:白血病与弥散性血管内凝血]
Rinsho Byori. 1991 Jul;39(7):736-42.
6
[Clinical usefulness of the measurements of plasmin-alpha 2-plasmin inhibitor complex and plasma tissue factor activity in patients with disseminated intravascular coagulation].[纤溶酶-α2-纤溶酶抑制物复合物及血浆组织因子活性测定在弥散性血管内凝血患者中的临床应用价值]
Rinsho Byori. 1996 Aug;44(8):750-6.
7
[A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].一种用于血栓形成和生命预后的新型分子标志物——可溶性纤维蛋白单体-纤维蛋白原复合物(SF)测定的临床应用价值
Rinsho Byori. 2004 Apr;52(4):355-61.
8
Determination of plasma soluble fibrin using a new ELISA method in patients with disseminated intravascular coagulation.采用新型酶联免疫吸附测定法测定弥散性血管内凝血患者血浆可溶性纤维蛋白
Am J Hematol. 1996 Mar;51(3):186-91. doi: 10.1002/(SICI)1096-8652(199603)51:3<186::AID-AJH2>3.0.CO;2-T.
9
Hemostatic molecular markers before the onset of disseminated intravascular coagulation.弥散性血管内凝血发作前的止血分子标志物。
Am J Hematol. 1999 Apr;60(4):273-8. doi: 10.1002/(sici)1096-8652(199904)60:4<273::aid-ajh4>3.0.co;2-n.
10
Monoclonal antibody specific for tissue factor pathway inhibitor-factor Xa complex: its characterization and application to plasmas from patients with disseminated intravascular coagulation and pre-disseminated intravascular coagulation.针对组织因子途径抑制物-因子Xa复合物的单克隆抗体:其特性及在弥散性血管内凝血和弥散性血管内凝血前期患者血浆中的应用
Blood Coagul Fibrinolysis. 1999 Sep;10(6):309-19.